GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for probable dual-specificity RNA methyltransferase rlmn (C1AFZ5)

Analyse AlphaFold monomer V2.0 prediction for probable dual-specificity RNA… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
C1AFZ5
Type
protein
Length
364 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xB05a6C07895e32B47A59E248baa07d66d77b0e17
Molecule
Probable dual-specificity RNA methyltransferase rlmn
UniProt
C1AFZ5
Pockets
2 · best druggability 0.78

Structure

1 distinct chain · 41% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProbable dual-specificity RNA methyltransferase rlmnprotein36441% helix, 20% strandC1AFZ5

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14440.780.8658empty
2730.380.7813empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.